Nucleophosmin 1 (NPM1), a nucleolar phosphoprotein, suppresses tumour immunogenicity by binding to IRF1 and preventing its association with the NLRC5 and CIITA promoters. This evidence concerns the gene NLRC5 and neoplasm.